These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 12445486

  • 1. Endothelial function in patients with peripheral vascular disease: influence of prostaglandin E1.
    Weiss T, Fischer D, Hausmann D, Weiss C.
    Prostaglandins Leukot Essent Fatty Acids; 2002 Nov; 67(5):277-81. PubMed ID: 12445486
    [Abstract] [Full Text] [Related]

  • 2. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease.
    Böger RH, Bode-Böger SM, Thiele W, Creutzig A, Alexander K, Frölich JC.
    J Am Coll Cardiol; 1998 Nov; 32(5):1336-44. PubMed ID: 9809945
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication.
    Mangiafico RA, Malatino LS, Santonocito M, Messina R, Attinà T, Dell'Arte S, Sarnataro F.
    Int J Clin Pharmacol Ther; 1999 Jul; 37(7):347-51. PubMed ID: 10442509
    [Abstract] [Full Text] [Related]

  • 10. Treatment of patients with peripheral arterial occlusive disease Fontaine stage IV with intravenous iloprost and PGE1: a randomized open controlled study.
    Altstaedt HO, Berzewski B, Breddin HK, Brockhaus W, Bruhn HD, Cachovan M, Diehm C, Dörrler J, Franke CS, Gruss JD.
    Prostaglandins Leukot Essent Fatty Acids; 1993 Aug; 49(2):573-8. PubMed ID: 7692455
    [Abstract] [Full Text] [Related]

  • 11. The LargPAD Trial: Phase IIA evaluation of l-arginine infusion in patients with peripheral arterial disease.
    Kashyap VS, Lakin RO, Campos P, Allemang M, Kim A, Sarac TP, Hausladen A, Stamler JS.
    J Vasc Surg; 2017 Jul; 66(1):187-194. PubMed ID: 28366306
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Neutrophil function in peripheral arterial occlusive disease: the effects of prostaglandin E1.
    Weiss T, Eckstein H, Weiss C, Diehm C.
    Vasc Med; 1998 Jul; 3(3):171-5. PubMed ID: 9892509
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of intravenous and intra-arterial infusions of prostaglandin E1 on canine hindlimb blood flow distribution.
    Lynch TG, Hobson RW, Barbalinardo JP, Kerr JC.
    Surgery; 1984 Jul; 96(1):35-41. PubMed ID: 6539953
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Prostaglandin E1 in therapy of peripheral arterial occlusive disease].
    Sinzinger H, Rogatti W.
    Wien Klin Wochenschr; 1991 Jul; 103(18):558-65. PubMed ID: 1750223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.